EIP
ABBV icon

Essential Investment Partners’s AbbVie ABBV Stock Holding History

Essential Investment Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.63M Sell
14,411
-968
-6% -$208K 2.91% 7
2026
Q1 		$3.34M Buy
15,379
+277
+2% +$61.4K 3.1% 5
2025
Q4 		$3.45M Buy
+15,102
New +$3.44M 3.25% 6

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Essential Investment Partners's ABBV Position: Q2 2026 in Review

Essential Investment Partners reduced its AbbVie (ABBV) stake by 6.3% in Q2 2026, selling an estimated $208K and leaving 14,411 shares worth $3.63M. The position accounts for 2.91% of the portfolio, ranked #7.

Essential Investment Partners first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 1,174 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Essential Investment Partners held 14,411 shares of AbbVie worth $3.63M as of Q2 2026.
  • Essential Investment Partners sold 968 AbbVie shares in Q2 2026, an estimated $208K.
  • AbbVie made up 2.91% of Essential Investment Partners's portfolio in Q2 2026, its #7 holding.
  • Essential Investment Partners first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 1,174 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Essential Investment Partners's 13F filing for Q2 2026, filed 15 Jul 2026.